Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Alvotech - Ordinary Shares
(NQ:
ALVO
)
5.175
+0.115 (+2.27%)
Streaming Delayed Price
Updated: 3:35 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
241,965
Open
5.120
Bid (Size)
5.170 (900)
Ask (Size)
5.180 (500)
Prev. Close
5.060
Today's Range
5.065 - 5.320
52wk Range
4.700 - 13.70
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)
November 20, 2025
From
Alvotech
Via
GlobeNewswire
ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP
November 19, 2025
From
Kirby McInerney LLP
Via
Business Wire
Performance
YTD
-60.7%
-60.7%
1 Month
-39.3%
-39.3%
3 Month
-38.9%
-38.9%
6 Month
-47.9%
-47.9%
1 Year
-58.3%
-58.3%
More News
Read More
Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
November 13, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Regencell, Beyond Meat, Alvotech, and Camping World and Encourages Investors to Contact the Firm
November 12, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
November 12, 2025
From
Alvotech
Via
GlobeNewswire
Uncovering Potential: Alvotech's Earnings Preview
↗
November 11, 2025
Via
Benzinga
UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept)
November 10, 2025
From
Alvotech
Via
GlobeNewswire
ALVOTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating Alvotech on Behalf of Alvotech Stockholders and Encourages Investors to Contact the Firm
November 07, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
November 06, 2025
From
Alvotech
Via
GlobeNewswire
ALVOTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating Alvotech on Behalf of Alvotech Stockholders and Encourages Investors to Contact the Firm
November 05, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Alvotech INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALVO)
November 04, 2025
From
Kirby McInerney LLP
Via
GlobeNewswire
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
November 04, 2025
From
Alvotech
Via
GlobeNewswire
This Kimberly-Clark Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
↗
November 04, 2025
Via
Benzinga
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November
↗
November 04, 2025
Via
Benzinga
Which stocks are moving on Monday?
↗
November 03, 2025
Via
Chartmill
Gold Edges Higher; ISM Manufacturing PMI Falls In October
↗
November 03, 2025
Via
Benzinga
Alvotech Shares Plunge 33% After FDA Flags Issues
↗
November 03, 2025
Via
Benzinga
Top movers analysis in the middle of the day on 2025-11-03: top gainers and losers in today's session.
↗
November 03, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 03, 2025
Via
Benzinga
Gapping stocks in Monday's session
↗
November 03, 2025
Via
Chartmill
Discover the top movers in Monday's pre-market session.
↗
November 03, 2025
Via
Chartmill
Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
November 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 03, 2025
Via
Benzinga
Why Lucas GC Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket
↗
November 03, 2025
Via
Benzinga
Frequently Asked Questions
Is Alvotech - Ordinary Shares publicly traded?
Yes, Alvotech - Ordinary Shares is publicly traded.
What exchange does Alvotech - Ordinary Shares trade on?
Alvotech - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alvotech - Ordinary Shares?
The ticker symbol for Alvotech - Ordinary Shares is ALVO on the Nasdaq Stock Market
What is the current price of Alvotech - Ordinary Shares?
The current price of Alvotech - Ordinary Shares is 5.175
When was Alvotech - Ordinary Shares last traded?
The last trade of Alvotech - Ordinary Shares was at 11/21/25 03:35 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today